Vistagen Therapeutics, Inc. VTGN
0.16 USD 0.00 (-0.85%)
At closeNov 6, 2026, 6:57 PM EST
0.16 0.00 0.00%
After hours · Nov 6, 6:57 PM ET
0.1638 Day range 0.1769
0.1638 52-week range 5.14
- YTD
- -75.18%
- 1 year
- -95.93%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 1.27M | 486.00K | 1.06M | -227.00K | 1.11M | |
| 1.27M | 486.00K | 1.06M | -227.00K | 1.11M | |
| -72.13M | -55.97M | -33.02M | -59.27M | -47.78M | |
| -69.69M | -51.42M | -29.36M | -59.25M | -47.76M | |
| -1.83 | -1.67 | -1.52 | -8.51 | -7.38 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 30.79M | 67.13M | 119.17M | 16.64M | 68.14M | |
| 48.56M | 84.34M | 123.65M | 21.09M | 74.64M | |
| 13.04M | 13.95M | 9.37M | 9.01M | 9.93M | |
| 1.04M | 1.51M | 2.12M | 2.71M | 3.04M | |
| 35.52M | 70.39M | 114.29M | 12.08M | 64.72M |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -66.44M | -42.10M | -25.81M | -49.72M | -45.26M | |
| -877.00K | -13.15M | -61.00K | -740.00K | -200.40K | |
| 30.97M | 3.21M | 128.40M | -1.04M | 10.48M | |
| -151.00K | -191.00K | -61.00K | -212.00K | -200.40K | |
| -36.34M | -52.03M | 102.53M | -51.50M | -34.97M |